Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08 Novembro 2023 - 10:00AM
Business Wire
As required by the rules of the Nasdaq Stock Market, Twist
Bioscience Corporation (NASDAQ: TWST), a company enabling customers
to succeed through its offering of high-quality synthetic DNA using
its silicon platform, today announced that it has granted a total
of 130,400 restricted stock units (“RSUs”) to 15 recently hired
individuals as an inducement material to their acceptance of
employment with Twist. The employment inducement awards were
granted under Twist’s Inducement Equity Incentive Plan and related
form of restricted stock award agreement in accordance with Nasdaq
Listing Rule 5635(c)(4).
The inducement plan is used exclusively for the grant of equity
awards to individuals who were not previously employees of Twist,
or following a bona fide period of non-employment, as an inducement
material to such individuals entering into employment with Twist,
pursuant to Nasdaq Listing Rule 5635(c)(4).
The RSUs vest over a 48-month period for each employee as
follows: 25% vests on the one year anniversary of the start date of
the employee (the “Vesting Commencement Date”), and 1/16 of the
RUSs vests on each quarterly anniversary of the Vesting
Commencement Date thereafter, subject to the employee’s continued
service through each vesting date.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic
biology and genomics company that has developed a disruptive DNA
synthesis platform to industrialize the engineering of biology. The
core of the platform is a proprietary technology that pioneers a
new method of manufacturing synthetic DNA by “writing” DNA on a
silicon chip. Twist is leveraging its unique technology to
manufacture a broad range of synthetic DNA-based products,
including synthetic genes, tools for next-generation sequencing
(NGS) preparation, and antibody libraries for drug discovery and
development. Twist is also pursuing longer-term opportunities in
digital data storage in DNA and biologics drug discovery. Twist
makes products for use across many industries including healthcare,
industrial chemicals, agriculture and academic research.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231108947837/en/
For Investors: Angela Bitting SVP, Corporate Affairs
925-202-6211 abitting@twistbioscience.com
For Media: Amanda Houlihan Communications Generalist
774-265-5334 ahoulihan@twistbioscience.com
Twist Bioscience (NASDAQ:TWST)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Twist Bioscience (NASDAQ:TWST)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024